RYTVELA
RYTVELA is a deriviative of the peptide antagonist of interleukin-1 receptor 1 (IL-1R1) d- (RYTVELA) that contains all L-amino acids[1].
Product Specifications
CAS Number
1200829-06-6
UNSPSC
12352209
Target
Drug Isomer
Related Pathways
Others
Field of Research
Others
Purity
98.89
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@@H](N)CCCNC(N)=N)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O
Molecular Formula
C38H62N10O12
Molecular Weight
850.96
References & Citations
[1]Christiane Quiniou, et al. Interleukin-1 and ischemic brain injury in the newborn: Development of a small molecule inhibitor of IL-1 receptor. Semin. Semin Perinatol. 2008 Oct;32 (5) :325-33.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP301992 20 µg
GRO alpha (CXCL1) (NM_001511) Human Recombinant Protein
Sign In for Pricing
View Details MBS1314423-01 0.02 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica Beta-glucosidase 13 (BGLU13)
Sign In for Pricing
View Details MBS1314423-02 0.02 mg (Yeast)
Recombinant Oryza sativa subsp. japonica Beta-glucosidase 13 (BGLU13)
Sign In for Pricing
View Details MBS1314423-03 0.1 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica Beta-glucosidase 13 (BGLU13)
Sign In for Pricing
View Details